In September Synlait posted an 11 per cent gain in full-year profit and flagged further growth this year while signalling a move into branded consumer goods. Its shares touched a record high $8.25 on October 30.
"From this platform, the company is looking for a CEO with the skills and experiences to take Synlait up another level," chair Graeme Milne said in a statement.
"We have already signalled to shareholders our intention to continue to develop our infant formula business, and enter new categories where there are significant opportunities."
Discussing the move into new markets on a conference call in September, Penno said: "Up until now we've been strictly B2B, which has been very important during start-up."
The company would move into branded products "where no conflict exists with existing partnerships" which meant it was "unlikely to be in infant formula", where companies such as A2 have very strong brands.
"We do see areas in new categories that could be Synlait branded," he said.
In August Synlait announced plans to triple sales of infant formula to Sichuan-based New Hope Nutritionals, which is already its second-largest customer for finished infant formula and its largest under a Chinese label. Synlait took a 25 per cent stake in New Hope in 2015.